Compumedics
- Short interest
- 0.01%
- −0.01 pp 30d
- as of 22 Oct 2025
- Reported shorts
- 10K
- Shares on issue
- 192.218M
Compumedics (CMP) Short Interest
Compumedics (ASX:CMP) had 0.01% of shares reported as short positions as of 22 Oct 2025, representing 10,000 shares. Compumedics operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Compumedics
Compumedics is involved in the development and commercialization of computer-based patient monitoring and diagnostic systems. The company focuses on sleep, brain, and ultrasonic blood-flow monitoring technologies, offering a range of diagnostic solutions and devices. They operate globally, providing products and services to various healthcare sectors.
Company profile →Compumedics (ASX:CMP) has 0.01% of its shares on issue reported as short positions as of 22 Oct 2025, or about 10,000 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. CMP is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads CMP today
- Zanger BreakoutWatchScore 41rank 197 of 1942
- CAN SLIMWatchScore 20rank 667 of 1541
- Minervini Trend TemplateNot a candidate
- Crowded-Short BreakoutWatchScore 10rank 915 of 1500
- Quality compoundersWatchScore 25rank 598 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
CMP fundamentals
In the year to 30 Jun 2026, Compumedics (ASX:CMP) recorded revenue of A$60.3M and net profit after tax of A$253.0K. A year earlier it recorded revenue of A$50.8M and a net loss after tax of A$1.3M. Year-on-year growth: revenue +18.5% (FY). Net margin 0.4% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest CMP news
All news- Appendix 4G
asx · 30 Sept 2026
- Corporate Governance Statement
asx · 30 Sept 2026
- Proxy Form
asx · 30 Sept 2026
Company details
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss CMP
Start a research thread or post the first pulse update